Advertisment

Weight Loss Drugs and Bariatric Surgery: A Comprehensive Guide to Benefits and Risks

author-image
Zara Nwosu
New Update
NULL

Weight Loss Drugs and Bariatric Surgery: A Comprehensive Guide to Benefits and Risks

Advertisment

Obesity is a growing global health issue that requires effective and efficient solutions. One of the strategies that have emerged in recent years is the use of weight loss drugs in combination with bariatric surgery. This combined approach offers potential benefits and risks which individuals should consider carefully before opting for this treatment route. This article delves into the intricacies of this approach, providing valuable insights and practical advice to our readers.

Advertisment

Exploring the Combined Approach

The idea of pairing weight loss drugs with bariatric surgery is a relatively new concept. The premise is to enhance the effects of the surgery, resulting in improved weight loss and metabolic health. This approach utilizes new obesity drugs, developed to mimic naturally occurring hormones. The goal is to lower costs and increase supply, however, there are challenges to consider.

The Challenges of Weight Loss Drugs

Advertisment

Currently, the existing weight loss drugs are large molecules, expensive, and time-consuming to manufacture. This results in access issues and increased competition, driving up prices for consumers. One of the drugs currently in development is orforglipron, which is smaller, easier and cheaper to produce, and an oral pill. However, it's important to note that the collection of weight loss drugs can be confusing. This is due to the FDA approving the same chemical drug for different conditions and companies giving different brand names to the drug based on the condition it treats.

A Closer Look at Specific Drugs: Ozempic and Wegovy

Ozempic, a once-weekly injectable medication, is formulated to help adults with type 2 diabetes manage their blood sugar. However, it has been found to also aid in weight loss. Although not officially a weight loss drug, the active ingredient in Ozempic, known as semaglutide, is FDA approved at higher doses for treating individuals living with obesity and other weight-related medical problems under the name Wegovy. A large clinical trial showed adults who took semaglutide lost 14.9% of their body weight compared with 2.4% for those who took the placebo. However, it's crucial to note that Ozempic is FDA approved for the treatment of diabetes only and is not a weight loss medication.

Advertisment

The Benefits and Risks of the Combined Approach

Using weight loss drugs in combination with bariatric surgery can help patients achieve greater weight loss and improve their overall health outcomes. However, this approach also comes with potential risks and side effects. These can vary depending on the individual's health status and the specific drug used. Therefore, it's critical to consult with a healthcare professional before starting any medication.

Considerations for Adolescents

While this article primarily focuses on adults, it's worth noting that there is also research being conducted on the use of anti-obesity medication for adolescent metabolic and bariatric surgery patients. Like adults, adolescents can potentially benefit from this combined approach, but the risks and considerations may be different for this age group.

In conclusion, the use of weight loss drugs in combination with bariatric surgery offers a promising approach for tackling obesity. However, individuals should carefully consider the potential benefits and risks, and always consult with healthcare professionals before starting any new treatment.

Advertisment
Chat with Dr. Medriva !